Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
docetaxel (taxotere) (3 trials)
erlotinib (tarceva) (1 trial)
gemcitabine (gemzar) (2 trials)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lung Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (3 total)